SMART FOR LIFE INC (SMFL)

US83204U5092 - Common Stock

0.4801  0 (-1.01%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to SMFL. SMFL was compared to 37 industry peers in the Personal Care Products industry. Both the profitability and financial health of SMFL have multiple concerns. While showing a medium growth rate, SMFL is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

SMFL had negative earnings in the past year.
SMFL had a negative operating cash flow in the past year.

1.2 Ratios

SMFL has a Return On Assets of -81.87%. This is amonst the worse of the industry: SMFL underperforms 83.78% of its industry peers.
With a Return On Equity value of -2201.05%, SMFL is not doing good in the industry: 89.19% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -81.87%
ROE -2201.05%
ROIC N/A
ROA(3y)-102.85%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 14.23%, SMFL is not doing good in the industry: 89.19% of the companies in the same industry are doing better.
SMFL's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for SMFL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y134.91%
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

SMFL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SMFL has been increased compared to 1 year ago.
Compared to 1 year ago, SMFL has an improved debt to assets ratio.

2.2 Solvency

SMFL has an Altman-Z score of -5.13. This is a bad value and indicates that SMFL is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -5.13, SMFL is doing worse than 86.49% of the companies in the same industry.
SMFL has a Debt/Equity ratio of 8.96. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 8.96, SMFL is not doing good in the industry: 86.49% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 8.96
Debt/FCF N/A
Altman-Z -5.13
ROIC/WACCN/A
WACC15.68%

2.3 Liquidity

SMFL has a Current Ratio of 0.18. This is a bad value and indicates that SMFL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.18, SMFL is not doing good in the industry: 94.59% of the companies in the same industry are doing better.
SMFL has a Quick Ratio of 0.18. This is a bad value and indicates that SMFL is not financially healthy enough and could expect problems in meeting its short term obligations.
SMFL's Quick ratio of 0.04 is on the low side compared to the rest of the industry. SMFL is outperformed by 97.30% of its industry peers.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.04

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 57.11% over the past year.
The Revenue for SMFL has decreased by -39.44% in the past year. This is quite bad
SMFL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 96.00% yearly.
EPS 1Y (TTM)57.11%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-10628.57%
Revenue 1Y (TTM)-39.44%
Revenue growth 3Y96%
Revenue growth 5YN/A
Revenue growth Q2Q-48.69%

3.2 Future

The Earnings Per Share is expected to grow by 24.77% on average over the next years. This is a very strong growth
SMFL is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.83% yearly.
EPS Next Y89.59%
EPS Next 2Y41.4%
EPS Next 3Y24.77%
EPS Next 5YN/A
Revenue Next Year-35.28%
Revenue Next 2Y-15.63%
Revenue Next 3Y-7.83%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

SMFL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SMFL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as SMFL's earnings are expected to grow with 24.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.4%
EPS Next 3Y24.77%

0

5. Dividend

5.1 Amount

No dividends for SMFL!.
Industry RankSector Rank
Dividend Yield N/A

SMART FOR LIFE INC

NASDAQ:SMFL (4/18/2024, 11:17:07 AM)

0.4801

0 (-1.01%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap384.08K
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -81.87%
ROE -2201.05%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 14.23%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 8.96
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.18
Quick Ratio 0.04
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)57.11%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y89.59%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-39.44%
Revenue growth 3Y96%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y